Forbes November 12, 2024
Since its founding in 2010, Moderna has aimed to redefine medicine by pioneering messenger RNA (abbreviated mRNA) technology. mRNA is a type of single-stranded RNA involved in protein synthesis. Moderna’s mission has transformed the company into a global leader in biotechnology, especially following the success of its COVID-19 vaccine. The company’s innovative approach harnesses mRNA to prompt the body to produce proteins that combat diseases. Yet, underpinning Moderna’s scientific ambitions is an equally sophisticated technological foundation that enables the company to operate at the scale, speed and complexity demanded by its goals. As Brad Miller, Moderna’s Chief Information Officer, emphasized in a recent conversation, technology isn’t merely a support function; it’s a “core digital part” of the company’s DNA, integrating...
Today's Sponsors
Today's Sponsor